Exact Sciences
EXAS
#1154
Rank
โ‚น1.938 T
Marketcap
โ‚น10,153
Share price
0.00%
Change (1 day)
112.59%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): -โ‚น456.52

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -โ‚น514.87. In 2024 the company made an earnings per share (EPS) of -โ‚น539.06.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น456.52-15.31%
2024-โ‚น539.06
2022-โ‚น342.602.31%
2021-โ‚น334.86-38.54%
2020-โ‚น544.87692.96%
2019-โ‚น68.71-50.69%
2018-โ‚น139.3644%
2017-โ‚น96.78-39.39%
2016-โ‚น159.69-2.94%
2015-โ‚น164.5337.1%
2014-โ‚น120.0179.71%
2013-โ‚น66.78-21.59%
2012-โ‚น85.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น184.17-135.77%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
โ‚น139.36-127.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
โ‚น32.91-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-โ‚น115.17-77.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-โ‚น4,926 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA